{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:39:20Z","timestamp":1788143960637,"version":"build-2803163510"},"reference-count":40,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Mhealth Uhealth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anticoagulation management is important in preventing complications in patients undergoing cardiac valve replacement. The development of mobile apps offers new opportunities for the management of long-term anticoagulants. However, there is a lack of randomized controlled trials evaluating the effectiveness, safety, cost-effectiveness, and user demand for internet-based anticoagulation management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to evaluate the efficacy, safety, and cost-effectiveness of a 3-month warfarin dose adjustment mobile app Alfalfa compared to offline management in patients postcardiac valve replacement. We also explored the app\u2019s feasibility on user satisfaction and demand.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study was a randomized controlled trial with assessments conducted at baseline and at a 3-month follow-up. Participants were eligible if they had been on warfarin therapy for at least 3 months, received warfarin management either through the Alfalfa app or through pharmacist-led anticoagulation outpatient clinic visits, consented to regular follow-ups, and had not experienced serious bleeding or thrombotic events in the 3 months before warfarin treatment. A\n                      <jats:italic>P<\/jats:italic>\n                      value of \u2264.05 was considered statistically significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 405 participants were included in the analysis. The time in therapeutic range was significantly higher in the Alfalfa app group than in the offline group (66.46% vs 46.65%,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.001). Participants in the Alfalfa app group had a higher monitoring frequency (8.14 vs 4.47,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.001) and a greater percentage of international normalized ratio values within the target range (896\/1660, 53.98% vs 346\/899, 38.49%;\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.001) than those in the offline group. In addition, the Alfalfa app group exhibited lower rates of subtherapeutic (235\/1660, 14.16% vs 152\/899, 16.91%;\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.05) and extreme subtherapeutic international normalized ratio values (273\/1660, 16.45% vs 186\/899, 20.69%;\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.05) than the offline group. However, the incidence of minor bleeding was higher in the Alfalfa app group (12\/204, 5.9% vs 3\/201, 1.5%;\n                      <jats:italic>P<\/jats:italic>\n                      =.02). In terms of cost-effectiveness, the Alfalfa app group had a significantly lower average cost per test (42.37 vs 78.3,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.001), average time per test (47.42 vs 90.74,\n                      <jats:italic>P<\/jats:italic>\n                      &lt;.001), and cost-effectiveness ratio (385.9 vs 662.9) than the offline group. A total of 86 participants completed the satisfaction questionnaire, and the vast majority of participants expressed high levels of satisfaction with the Alfalfa App, while also providing further suggestions for improvement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The integration of \u201cInternet+Pharmacy Care\u201d using the Alfalfa App can improve the effectiveness of warfarin anticoagulation management in patients following heart valve surgery. The Alfalfa app provides a more efficient, secure, and cost-effective solution to warfarin management than traditional offline methods.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/53586","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T22:54:34Z","timestamp":1743029674000},"page":"e53586-e53586","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy, Safety, and Cost-Effectiveness of \u201cInternet + Pharmacy Care\u201d Via the Alfalfa App in Warfarin Therapy Management After Cardiac Valve Replacement: Randomized Controlled Trial"],"prefix":"10.2196","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3857-6115","authenticated-orcid":false,"given":"Yiyi","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3078-5167","authenticated-orcid":false,"given":"Weizhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3786-8388","authenticated-orcid":false,"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8868-458X","authenticated-orcid":false,"given":"Jiangya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0299-3087","authenticated-orcid":false,"given":"Yuanyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4675-8162","authenticated-orcid":false,"given":"Zhiying","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5629-0348","authenticated-orcid":false,"given":"Jinhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"issue":"6","key":"R1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12062178","article-title":"The global burden of valvular heart disease: From clinical epidemiology to management","volume":"12","author":"Santangelo","journal-title":"J Clin Med"},{"issue":"4","key":"R2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.13498\/j.cnki.chin.j.ecc.2022.04.02","article-title":"White book of Chinese cardiovascular surgery and extracorporeal circulation in 2019","volume":"20","author":"Chinese Society of Extracorporeal Circulation","journal-title":"Chinese Journal of Extracorporeal Circulation"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01527","article-title":"Effect of gene-based warfarin dosing on anticoagulation control and clinical events in a real-world setting","volume":"10","author":"Zhang","journal-title":"Front Pharmacol"},{"issue":"6","key":"R4","doi-asserted-by":"publisher","first-page":"101632","DOI":"10.1016\/j.cpcardiol.2023.101632","article-title":"Optimal anticoagulation on TAVI patients based on thrombotic and bleeding risk and the challenge beyond: A systematic review and meta-analysis","volume":"48","author":"Tsoumas","journal-title":"Curr Probl Cardiol"},{"issue":"3","key":"R5","doi-asserted-by":"publisher","first-page":"101531","DOI":"10.1016\/j.cpcardiol.2022.101531","article-title":"Cardiac rehabilitation after TAVI -A systematic review and meta-analysis","volume":"48","author":"Oz","journal-title":"Curr Probl Cardiol"},{"issue":"9224","key":"R6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0140-6736(00)02470-3","article-title":"Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison","volume":"356","author":"Cromheecke","journal-title":"Lancet"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2017.07.016","article-title":"Outcomes of an online pharmacist-managed anticoagulation clinic for individuals on warfarin therapy living in rural communities","volume":"157","author":"Zhang","journal-title":"Thromb Res"},{"issue":"12","key":"R8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032949","article-title":"New warfarin anticoagulation management model after heart valve surgery: rationale and design of a prospective, multicentre, randomised trial to compare an internet-based warfarin anticoagulation management model with the traditional warfarin management model","volume":"9","author":"Zhu","journal-title":"BMJ Open"},{"issue":"6","key":"R9","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1007\/s11096-018-0731-8","article-title":"The effect of online versus hospital warfarin management on patient outcomes: a systematic review and meta-analysis","volume":"40","author":"Xia","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"R10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1136\/jclinpath-2015-203168","article-title":"Assessing the utility of an online registry for patients monitoring their own warfarin therapy","volume":"69","author":"McCahon","journal-title":"J Clin Pathol"},{"issue":"5","key":"R11","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1007\/s11096-018-0674-0","article-title":"Outcomes of warfarin therapy managed by pharmacists via hospital anticoagulation clinic versus online anticoagulation clinic","volume":"40","author":"Cao","journal-title":"Int J Clin Pharm"},{"issue":"43","key":"R12","doi-asserted-by":"publisher","first-page":"E1460","DOI":"10.1503\/cmaj.220138","article-title":"Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update","volume":"194","author":"Jain","journal-title":"CMAJ"},{"issue":"2 Suppl","key":"R13","doi-asserted-by":"publisher","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Holbrook","journal-title":"Chest"},{"issue":"9","key":"R14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031730","article-title":"Comparison of the outcomes of warfarin therapy and economics by online and offline anticoagulation management models: protocol for a randomised controlled trial","volume":"9","author":"Xia","journal-title":"BMJ Open"},{"issue":"3","key":"R15","doi-asserted-by":"publisher","DOI":"10.2196\/23332","article-title":"Effectiveness of the Alfalfa app in warfarin therapy management for patients undergoing venous thrombosis prevention and treatment: Cohort study","volume":"9","author":"Cao","journal-title":"JMIR Mhealth Uhealth"},{"issue":"1","key":"R16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.sapharm.2004.12.002","article-title":"The development and performance validation of a tool to assess patient anticoagulation knowledge","volume":"1","author":"Briggs","journal-title":"Res Social Adm Pharm"},{"issue":"3","key":"R17","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","journal-title":"Thromb Haemost"},{"issue":"2","key":"R18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.thromres.2015.06.007","article-title":"Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink","volume":"136","author":"Macedo","journal-title":"Thromb Res"},{"issue":"1","key":"R19","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06882-7","article-title":"Evaluation of the \u201csafe multidisciplinary app-assisted remote patient-self-testing (SMART) model\u201d for warfarin home management during the COVID-19 pandemic: study protocol of a multi-center randomized controlled trial","volume":"21","author":"Chen","journal-title":"BMC Health Serv Res"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Hadlock GC Burnett AE Nutescu EA . Warfarin. In: GD B MB S , editors. Anticoagulation Therapy. Springer; 2018. [doi: 10.1007\/978-3-319-73709-6_2]","DOI":"10.1007\/978-3-319-73709-6_2"},{"issue":"1","key":"R21","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0268-9","article-title":"Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVAL","volume":"13","author":"Prochaska","journal-title":"BMC Med"},{"issue":"4","key":"R22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","journal-title":"J Thromb Haemost"},{"issue":"3","key":"R23","first-page":"172","volume":"27","author":"Qian","journal-title":"chinese journal of clinical pharmacy"},{"issue":"9","key":"R24","doi-asserted-by":"publisher","DOI":"10.14009\/j.issn.1672-2124.2019.09.033","article-title":"Investigation and analysis of patients\u2019 satisfaction for clinical pharmacists in anticoagulation clinics","volume":"19","author":"He X,","journal-title":"Evaluation and Analysis of Drug Use in Hospitals of China"},{"issue":"12","key":"R25","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","journal-title":"Ann Intern Med"},{"issue":"2","key":"R26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/0897190017703506","article-title":"Clinical and financial outcomes evaluation of multimodal pharmacist warfarin management of a statewide urban and rural population","volume":"31","author":"Lee","journal-title":"J Pharm Pract"},{"issue":"10","key":"R27","first-page":"1060","volume":"86","author":"Manotti","journal-title":"Haematologica"},{"issue":"3","key":"R28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jtcvs.2012.03.088","article-title":"Anticoagulation early after mechanical valve replacement: improved management with patient self-testing","volume":"146","author":"Thompson","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"R29","doi-asserted-by":"publisher","DOI":"10.2196\/29529","article-title":"New internet-based warfarin anticoagulation management approach after mechanical heart valve replacement: Prospective, multicenter, randomized controlled trial","volume":"23","author":"Zhu","journal-title":"J Med Internet Res"},{"issue":"3","key":"R30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1089\/tmj.2010.0128","article-title":"Home management of oral anticoagulation via telemedicine versus conventional hospital-based treatment","volume":"17","author":"Christensen","journal-title":"Telemed J E Health"},{"issue":"410","key":"R31","first-page":"533","volume":"46","author":"Fitzmaurice","journal-title":"Br J Gen Pract"},{"issue":"15","key":"R32","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1001\/archinte.160.15.2343","article-title":"Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized, controlled trial","volume":"160","author":"Fitzmaurice","journal-title":"Arch Intern Med"},{"issue":"1","key":"R33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11239-021-02630-0","article-title":"Efficacy and safety of app-based remote warfarin management during COVID-19-related lockdown: a retrospective cohort study","volume":"54","author":"Jiang","journal-title":"J Thromb Thrombolysis"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S395578","article-title":"The value of anticoagulation management combining telemedicine and self-testing in cardiovascular diseases: A meta-analysis of randomized controlled trials","volume":"19","author":"Huang","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"R35","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1538-7836.2008.02959.x","article-title":"An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage","volume":"6","author":"Poller","journal-title":"J Thromb Haemost"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.2196\/48716","article-title":"Application of eHealth tools in anticoagulation management after cardiac valve replacement: Scoping review coupled with bibliometric analysis","volume":"12","author":"Wu","journal-title":"JMIR Mhealth Uhealth"},{"issue":"4","key":"R37","doi-asserted-by":"publisher","DOI":"10.2196\/mhealth.6510","article-title":"Processes and recommendations for creating mHealth apps for low-income populations","volume":"5","author":"Stephan","journal-title":"JMIR Mhealth Uhealth"},{"issue":"2","key":"R38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ejcts.2008.10.020","article-title":"Self-management program improves anticoagulation control and quality of life: a prospective randomized study","volume":"35","author":"Soliman Hamad","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"R39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/BF02934716","article-title":"Reorganisation of an anticoagulation clinic using a telemedicine system: description of the model and preliminary results","volume":"1","author":"Testa","journal-title":"Intern Emerg Med"},{"issue":"10","key":"R40","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/jamia\/ocac088","article-title":"Optimizing the dynamic treatment regime of in-hospital warfarin anticoagulation in patients after surgical valve replacement using reinforcement learning","volume":"29","author":"Zeng","journal-title":"J Am Med Inform Assoc"}],"container-title":["JMIR mHealth and uHealth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/mhealth.jmir.org\/2025\/1\/e53586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:39:26Z","timestamp":1782841166000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhealth.jmir.org\/2025\/1\/e53586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":40,"URL":"https:\/\/doi.org\/10.2196\/53586","relation":{},"ISSN":["2291-5222"],"issn-type":[{"value":"2291-5222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"article-number":"v13i6e53586"}}